Early ROS-mediated DNA damage and oxidative stress biomarkers in Monoclonal B Lymphocytosis.

[1]  Juliane C. Dohm,et al.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia , 2011, Nature.

[2]  R. Franco,et al.  Reactive oxygen species (ROS)--induced genetic and epigenetic alterations in human carcinogenesis. , 2011, Mutation research.

[3]  G. Morgan,et al.  Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  T. Economopoulos,et al.  Abnormalities of DNA repair mechanisms in common hematological malignancies , 2011, Leukemia & lymphoma.

[5]  R. Houlston,et al.  Inherited genetic susceptibility to monoclonal B-cell lymphocytosis. , 2010, Blood.

[6]  P. Ghia,et al.  CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it? , 2010, Seminars in cancer biology.

[7]  Neil E Caporaso,et al.  B-cell clones as early markers for chronic lymphocytic leukemia. , 2009, The New England journal of medicine.

[8]  S. Zehetmayer,et al.  DNA repair polymorphisms associated with cytogenetic subgroups in B‐cell chronic lymphocytic leukemia , 2009, Genes, chromosomes & cancer.

[9]  D. Rossi,et al.  The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors , 2009, British journal of haematology.

[10]  R. Lamuela-Raventós,et al.  Impact of cardiovascular risk factors on oxidative stress and DNA damage in a high risk Mediterranean population , 2009, Free radical research.

[11]  T. Shanafelt,et al.  Monoclonal B-cell lymphocytosis: definitions and natural history , 2009, Leukemia & lymphoma.

[12]  F. Bosch,et al.  Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia. , 2008, Cancer research.

[13]  Guy Pratt,et al.  A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia , 2008, Nature Genetics.

[14]  G. Dighiero.  Monoclonal B-cell lymphocytosis--a frequent premalignant condition. , 2008, The New England journal of medicine.

[15]  S. Richards,et al.  Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. , 2008, The New England journal of medicine.

[16]  M. Panayiotidis.  Reactive oxygen species (ROS) in multistage carcinogenesis. , 2008, Cancer letters.

[17]  Michael Hallek,et al.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. , 2008, Blood.

[18]  J. Cerhan,et al.  Susceptibility genes and B‐chronic lymphocytic leukaemia , 2007, British journal of haematology.

[19]  E. Sausville,et al.  Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine. , 2004, Blood.

[20]  Naim Uzun,et al.  Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[21]  W. Plunkett,et al.  Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents. , 2003, Blood.

[22]  C. Tormos,et al.  Antioxidant enzyme activities and the production of MDA and 8-oxo-dG in chronic lymphocytic leukemia. , 2001, Free radical biology & medicine.

[23]  L. Larcom,et al.  Chronic lymphocytic leukemia lymphocytes lack the capacity to repair UVC-induced lesions. , 2000, Mutation research.

[24]  J. Morrow,et al.  The isoprostanes. Current knowledge and directions for future research. , 1996, Biochemical pharmacology.

[25]  J. Lunec,et al.  Oxidative damage to DNA in patients with cystic fibrosis. , 1995, Free radical biology & medicine.

[26]  M. R. Oliva,et al.  The role of 8-hydroxy-2'-deoxyguanosine in rifamycin-induced DNA damage. , 1995, Free radical biology & medicine.

[27]  A. Ferraris,et al.  Increased glutathione in chronic lymphocytic leukemia lymphocytes , 1994, American journal of hematology.

[28]  P. Cerutti,et al.  Oxy-radical induced mutagenesis of hotspot codons 248 and 249 of the human p53 gene. , 1994, Oncogene.

[29]  E. Montserrat,et al.  5th International Workshop on Chronic Lymphocytic Leukemia. , 1992, Leukemia research.

[30]  A. Grollman,et al.  Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG , 1991, Nature.

[31]  R. Floyd.  The role of 8-hydroxyguanine in carcinogenesis. , 1990, Carcinogenesis.

[32]  R. Silber,et al.  Antioxidant enzymes in lymphocytes from normal subjects and patients with chronic lymphocytic leukaemia: increased glutathione peroxidase activity in CLL B lymphocytes , 1989, British journal of haematology.

[33]  S. Wong,et al.  Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. , 1987, Clinical chemistry.

[34]  E. Cadenas,et al.  Oxidative stress: damage to intact cells and organs. , 1985, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[35]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[36]  R C Gupta,et al.  Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[37]  H. Sies,et al.  Identification and quantitation of glutathione in hepatic protein mixed disulfides and its relationship to glutathione disulfide. , 1983, Biochemical pharmacology.

[38]  Mark J. Thomas,et al.  A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis , 1981, Cancer.

[39]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[40]  K. Blume,et al.  Enzymes of glutathione synthesis in patients with myeloproliferative disorders. , 1973, Clinica chimica acta; international journal of clinical chemistry.

[41]  G. Marti,et al.  Monoclonal B cell lymphocytosis: Clinical and population perspectives , 2010, Cytometry. Part B, Clinical cytometry.

[42]  P. Montuschi,et al.  Measurement of 8-isoprostane in exhaled breath condensate. , 2010, Methods in molecular biology.

[43]  J. Viña,et al.  Blood glutathione as an index of radiation-induced oxidative stress in mice and humans. , 1997, Free radical biology & medicine.

[44]  Y. Sun,et al.  Free radicals, antioxidant enzymes, and carcinogenesis. , 1990, Free radical biology & medicine.